| Strategy for drug discovery targeting zinc chelators for allergy treatment
Prof. Toshio Hirano, Osaka
University and Deputy Director of Riken Research
Center for Allergy and Immunology, first found that zinc ions are required for
initiation of allergic response. Upon allergic stimulation, granules in
mast cells and eosiophils migrate along the cyoskelton to the plasma membrane,
and finally fuse to plasma membrane and release chemical mediators. Zinc
ions are required for translocation of granules. We are developing therapeutics
to suppress allergic response by depriving zinc ion from a diseased site.
We believe that this should be effective for the treatment of diseases
such as atopic dermatitis and allergic rhinitis.
|